Revenue Dynamics YoY (Last Twelve Months): Renalytix Plc (RNLX)

Brandmark of Renalytix Plc (RNLX)

A liquidity deficit for bringing AI tests to market is forcing Renalytix Plc (RNLX) to seek emergency financing. The GURU.Markets terminal provides the annual revenue growth trend over a rolling 12-month period, where -36.40 is the current value of the metric. The development of KidneyIntelX relies on physician recognition and Medicare coverage, while the environmental vector is based on the digitalization of reporting and the minimization of bio-waste.

Renalytix, plc (RNLX) Sales Growth YoY (Last Twelve Months): for the period 02/11/2024 - 02/20/2024

Summary analytical data breakdowns for Renalytix (RNLX)

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Fundamental company valuation:Renalytix Plc
Original product of renalytix.com

This indicator measures the dynamics of cash inflows over a rolling year, allowing the investor to differentiate real organic growth from inflationary effects or demand stagnation. By analyzing the trajectory of the 12-month annual revenue change, one can see how the KidneyIntelX cloud AI platform scales testing volumes for millions of patients with minimal costs, ensuring the metric's high sensitivity to the expansion of the Renalytix Plc (RNLX) bioinformatic service.